Health ❯ Healthcare ❯ Patient Care ❯ Treatment Options

Targeted Therapy

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

EMA Panel Backs Conditional EU Approval for Ojemda in Pediatric Low-Grade Glioma